<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00202436</url>
  </required_header>
  <id_info>
    <org_study_id>PPO-C- 03-006</org_study_id>
    <nct_id>NCT00202436</nct_id>
  </id_info>
  <brief_title>Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy</brief_title>
  <official_title>Therapeutic Erythrocytapheresis as Treatment for Hemochromatosis Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanquin Research &amp; Blood Bank Divisions</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Atrium Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sanquin Research &amp; Blood Bank Divisions</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this project we plan to evaluate the effectiveness of erythrocytapheresis against
      phlebotomy, both regarding the impact on the reduction in iron overload as well as reduction
      in patient &quot;burden&quot;. Aspects of cost effectiveness will be included in the final analysis.
      Results of the study would allow decision-making based on Evidence Based Medicine on the
      &quot;best&quot; therapeutic options available for newly-diagnosed as well as existing primary
      hemochromatosis patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this project we plan to evaluate the effectiveness of erythrocytapheresis against
      phlebotomy, both regarding the impact on the reduction in iron overload as well as reduction
      in patient &quot;burden&quot;. Aspects of cost effectiveness will be included in the final analysis.
      The results of the study would allow decision-making based on Evidence Based Medicine on the
      &quot;best&quot; therapeutic options available for newly-diagnosed as well as existing primary
      hemochromatosis patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2004</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment duration and number of treatments</measure>
    <time_frame>Ferritine value 50 microgr/l</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Decline in hemoglobin levels, restitution in liver functions, patient discomfort en costs</measure>
    <time_frame>Ferritine value 50microgr/l</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hemochromatosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Phlebotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Erythrocytapheresis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Phlebotomy</intervention_name>
    <description>Removal of 500 ml whole blood</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <other_name>Bloodletting</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Erythrocytapheresis</intervention_name>
    <description>machinal removal of erythrocytes</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <other_name>Therapeutic erythrocytapheresis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hereditary haemochromatosis patients

        Exclusion Criteria:

          -  Malignancies, severe arrhythmias, congestive heart failure and/or recent angina,
             severe liver disease, epileptic seizures preceding in last 3 months before planned
             treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva Rombout, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sanquin Research and Blood Bank Divisions</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanquin Blood Bank Southeast Region</name>
      <address>
        <city>Maastricht</city>
        <zip>6229 GR</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.sanquinresearch.nl</url>
  </link>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>October 19, 2009</last_update_submitted>
  <last_update_submitted_qc>October 19, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr.Wim de Kort PhD</name_title>
    <organization>Sanquin Blood Bank South-east</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemochromatosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

